NovaBridge Biosciences (NBP) Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Non-Current Assets data on file, last reported at $43.0 million in Q4 2025.

• Non-Current Assets for Q4 2025 came in at $43.0 million, up 19.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $162.4 million (down 2.27% YoY), and the FY2025 annual result was $43.0 million, up 19.49% from the prior year.
• Non-Current Assets declined to $43.0 million in Q4 2025 per NBP's latest filing, from $44.6 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $209.5 million in Q4 2023 and troughed at $23.3 million in Q2 2024.
• A 5-year average of $90.4 million and a median of $44.6 million in 2025 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2021 and 2024: Non-Current Assets soared 186.85% in 2021, then tumbled 82.82% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $188.8 million in 2021, then climbed by 6.67% to $201.4 million in 2022, then increased by 4.01% to $209.5 million in 2023, then plunged by 82.82% to $36.0 million in 2024, then gained by 19.49% to $43.0 million in 2025.
• Business Quant data shows NBP's Non-Current Assets at $43.0 million in Q4 2025, $44.6 million in Q3 2025, and $39.1 million in Q2 2025.